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oseph F. Sabik, III, MD, FACC,
ugene H. Blackstone, MD, FACC
leveland, Ohio
actors Influencing Bypass Graft Patency
ver since the observation by Loop et al. (1) that internal
horacic arteries (ITA) are more effective coronary artery
ypass grafts than saphenous veins in prolonging patient
urvival and preventing recurrent ischemic events, cardio-
horacic surgeons have tried to improve the results of
urgical revascularization by using other arteries as bypass
onduits, such as the gastroepiploic, radial, and inferior
pigastric arteries (2–4). The better patient outcomes ob-
erved with ITA grafts are related to their excellent long-
erm stable patency (5). Saphenous vein graft patency is not
table; it declines with time from development of vein graft
rteriosclerosis. From 1 to 5 years after surgery, saphenous
ein grafts occlude at a rate of 1% to 2% per year,
ccelerating to 4% to 5% per year by 6 to 10 years. By 10
ears, only 50% to 60% of these grafts are patent, and only
ne-half of these are free of angiographic arteriosclerosis (6,7).
nlike saphenous veins, ITA grafts rarely develop arterioscle-
osis (4%), and only 1% develop important arteriosclerotic
uminal narrowing (8). This resistance to arteriosclerosis results
n 90% of ITA grafts being patent 10 years after surgery (5,6).
urgeons have hoped that other arterial grafts would behave
imilarly.
See page 120
However, factors other than arteriosclerosis influence
raft patency. An important factor affecting early arterial
raft patency is native coronary artery blood flow (5,6,9).
hen an arterial graft is used to bypass a coronary artery
ith only moderate proximal stenosis, the need for bypass
lood flow is low, causing the graft to constrict and fail.
his is consistent with the physiology of arteries. Unlike
aphenous veins, arteries are muscular and can autoregulate
heir lumen in response to blood flow demand. This
henomenon influencing arterial graft patency is referred to
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or them
merican College of Cardiology.
From the Cleveland Clinic, Cleveland, Ohio.s native coronary artery competitive blood flow, but be-
ause it is difficult to measure, maximum coronary artery
tenosis (either in the native artery proximal to the graft or
n the entire pathway between graft and aorta) is often used
s its surrogate.
hoice of Conduit
hese observations—that different factors influence arterial
nd vein graft patency and that they act at different times,
rteriosclerosis decreasing late vein graft patency and com-
etitive flow decreasing early arterial graft patency—
nfluence surgeons’ decisions about what conduit is most
ikely to be best (remain patent) for an individual coronary
rtery with a specific stenosis. Surgeons ask 2 questions
hen choosing between arterial and saphenous vein con-
uits: 1) is there a degree of coronary artery stenosis below
hich a saphenous vein graft will more likely remain patent
nd therefore be more effective than an arterial graft? and 2)
ow does this comparison change over time as vein grafts
ail from development of vein graft arteriosclerosis?
Answers to these questions have been reported for ITA
nd saphenous vein grafts. For all left-sided coronary
rteries and the posterior descending coronary artery, both
arly and late ITA graft patency is better than saphenous
ein graft patency at all levels of clinically important
50%) coronary artery stenosis and at all points in time (6).
herefore, an ITA should always be a more effective graft
han a saphenous vein for bypassing stenoses in these
oronary arteries or their branches. However, this is not true
or the right coronary artery (RCA). Early (5 years) after
urgery, saphenous vein grafts seem to have better patency
han ITA grafts unless the RCA is severely (80% to 90%)
tenosed; late (10 years) after surgery, however, ITA grafts
re more likely to be patent than saphenous vein grafts (6).
hus, early after surgical revascularization, ITA grafts are
ess effective than saphenous vein grafts when bypassing a
oderately stenosed main RCA; late after surgery, ITA
rafts are likely to be more effective. Therefore, ITA
rafting of the main RCA should be reserved until it is at
east 70% stenosed.
astroepiploic Artery Grafts
n this issue of the Journal, Glineur et al. (10) report an
nvestigation on the first of the aforementioned 2 questions
or gastroepiploic artery and saphenous vein grafts when
sed to bypass the RCA and its branches. They evaluate
hich pre-operative angiographic variables (surrogates for
ative coronary artery competitive flow) might influence
astroepiploic artery and saphenous vein graft patency 6
onths after coronary artery bypass surgery. Consecutive
atients were randomized to receive either a gastroepiploic
rtery (n  90) or a saphenous vein graft (n  82) to bypass
he posterior descending artery or posterolateral branch of
he RCA. Follow-up angiography was performed 6 to 8
onths post-operatively. The angiographic surrogates for
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127JACC Vol. 51, No. 2, 2008 Sabik III and Blackstone
January 15, 2008:126–8 Editorial Commentative coronary artery competitive blood flow used in the
nalysis were: 1) pre-operative maximum coronary artery
tenosis and 2) minimum lumen diameter. Other angio-
raphic variables included in their analysis were RCA
iameter, location of stenosis, run-off of RCA, and regional
all motion abnormality. At 6 months, there was a statis-
ically significant difference in functioning gastroepiploic
62%) and saphenous vein (85%) grafts. Gastroepiploic
atency increased as minimum lumen diameter decreased
surprisingly, coronary run-off was not associated with graft
atency). When minimum lumen diameter of the RCA was
(100% stenosed), all gastroepiploic grafts were patent,
hereas when it was 1.4 mm, only 5% were functioning.
he authors identified a threshold of 1 mm for minimum
umen diameter where gastroepiploic artery patency was
est. Not surprisingly, saphenous vein patency was much
ess influenced by competitive flow. The authors conclude
hat most saphenous vein grafts and only a minority of
astroepiploic grafts remain patent when RCA minimum
umen diameter is 1 mm and recommend that, in patients
ith RCA stenosis of intermediate severity, saphenous vein
rafts are preferable to gastroepiploic artery grafts.
omments
his is a well-done study that contributes important new
nowledge to our understanding of graft patency. The study
esign had many strengths. First, it was a randomized trial;
here are few randomized trials comparing conduits in
oronary artery bypass surgery, and this is the first to compare
aphenous vein and gastroepiploic artery grafts. Second, in
ddition to maximal percent stenosis, the authors for the
rst time use minimum lumen diameter as a surrogate for
ompetitive flow. Maximum percent stenosis is not as good
measure of competitive flow as minimum lumen diameter.
his makes physiologic sense: Competitive flow through a
0% stenosed, 5-mm RCA must be greater than that
hrough a similarly stenosed 2-mm artery. Using only
aximal coronary artery stenosis does not adjust for coro-
ary artery size, whereas minimum lumen diameter does. In
uture studies of the effect of competitive flow on graft
atency, minimum lumen diameter rather than maximal
oronary artery stenosis should be used as a surrogate for
ompetitive flow. The authors should be credited with this
mportant contribution. Third, a validated quantitative an-
iographic analysis was used to determine severity of coro-
ary artery stenosis. Although such methods are used
outinely in interventional cardiology studies, visual inspec-
ion with stenosis estimates is the norm in the published
urgical reports.
The principal findings of the article are valuable in that
hey will assist cardiothoracic surgeons in making conduit
ecisions for RCA revascularization. Surgeons should no
onger use only maximal coronary artery stenosis but instead
ely more on minimum lumen diameter. From the data in
his report, it seems that for coronary minimum lumen aiameters of 1 mm, gastroepiploic artery graft patency is
t least equivalent if not better than that of saphenous vein
rafts at 6 months. An important unanswered question is
hat happens to gastroepiploic artery graft patency in the
ong term, for little is known about this. Do they remain
atent like an ITA graft or gradually occlude like a saphe-
ous vein graft? Suma et al. (2) have reported that gastro-
piploic patency declines over time, from 91% at 1 year to
0% at 5 years to 62% at 10 years. If these percentages are
orrect, there does not seem to be much benefit of gastro-
piploic artery grafting. However, this would depend on the
ate of decline in patency compared with that of vein grafts.
hese are important unknowns, and hopefully, the authors
ill follow their patients longitudinally to answer these
uestions.
A missed opportunity for the authors was analyzing how
re-operative conduit variables influenced arterial graft pa-
ency. For example, how do conduit lumen diameter and
lood flow influence arterial graft patency? Such knowledge
ould assist surgeons in making conduit decisions. Although
he authors measured gastroepiploic diameter, this did not
eem to have been entered into the analysis. A larger arterial
onduit with greater blood flow is more likely to remain
atent, despite only moderate native coronary stenosis, than
smaller arterial conduit.
So, should an arterial graft ever be used to revascularize
he RCA? We (11) as well as Gilneur et al. (10) believe that,
esides using an ITA to graft the left anterior descending
oronary artery (LAD), a second arterial graft is beneficial.
owever, this is not widely accepted, as demonstrated by
ata from the Society of Thoracic Surgeons’ Adult Cardiac
ational Database: in 2003, only 3% to 4% of patients
ndergoing surgical coronary revascularization received bi-
ateral ITA grafts. It is also important to note that surgeons
ho do believe that bilateral ITA grafting has clinical
enefit preferentially use the second ITA to bypass the
econd most important (after the LAD) left-sided coronary
rtery, not the RCA. This preference is based on the
bservation that, owing to competitive flow, arterial grafts
o the RCA have a lower patency than when used to bypass
eft-sided coronary arteries (6). There is also no evidence
hat using an arterial graft to the RCA or its branches
onfers patient benefit. However, logic would dictate that if
gastroepiploic artery graft is more likely to remain patent
han a saphenous vein graft and therefore more effective, it
hould confer some patient benefit, such as angina relief.
his requires further investigation.
In summary, the report by Glineur et al. (10) is well done
nd adds important information on 6-month gastroepiploic
atency. It also sets the standard for how future studies of
omparative bypass conduit patency studies should be per-
ormed: in a randomized manner with quantitative analysis
f coronary stenosis. Although the study suggests that, for
atients with severe stenosis of the RCA, gastroepiploic
rtery grafts are more likely to be patent early after surgery,
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Editorial Comment January 15, 2008:126–8he important question is whether they are more effective
han saphenous vein grafting in the long term.
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